Showing 301-310 of 904 results for "".
Moisturizers for Skin Diseases: New Insights
https://practicaldermatology.com/topics/atopic-dermatitis/moisturizers-for-skin-diseases-new-insights/22977/Exploring Patient-Reported Outcomes Measures in Atopic Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/exploring-patient-reported-outcomes-measures-in-atopic-dermatitis/23886/Patient-reported outcomes may solve some of the challenges with measuring the physical and psychosocial manifestations.Drug-Induced Dermatomyositis
https://practicaldermatology.com/topics/atopic-dermatitis/drug-induced-dermatomyositis/23357/It’s common practice to screen for underlying malignancy in dermatomyositis, but it is also important to look for drug-induced disease.Barrier Repair: Where Do We Stand?
https://practicaldermatology.com/topics/general-topics/barrier-repair-where-do-we-stand/21455/An update on skin moisturization and the use of prescription barrier repair agents for atopic dermatitis.Investigational Oral Treatments for Psoriasis: A Review of Phase 2 and 3 Trials
https://practicaldermatology.com/topics/psoriasis/investigational-oral-treatments-for-psoriasis-a-review-of-phase-2-and-3-trials/23318/Although biologic medications have proven to be highly effective in the treatment of psoriasis, there remains a need for oral medications that offer similar success rates. Here’s a look in the pipeline.Acquired Dermal Macular Hyperpigmentation
https://practicaldermatology.com/topics/pigmentary-disorders/acquired-dermal-macular-hyperpigmentation/67257/Acquired dermal macular hyperpigmentation (ADMH) encompasses a group of chronic acquired pigmentary dermatoses characterized by the presence of dermal pigmentation.Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Seborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in aTri-State Analysis of the Distribution of Southeastern Dermatologists and Dermatology Residency Graduates Among Rural and Urban Areas
https://practicaldermatology.com/issues/november-2024/tri-state-analysis-distribution-southeastern-dermatologists-and-dermatology-residency-graduates-among-rural-and-urban-areas/29799/The nation faces a shortage of dermatologists, and this issue is most prevalent in rural areas. The objective of this study is to analyze the distribution of dermatologists and graduates of dermatology residency programs across the southeastern region and the factors that influence this distributionViewpoint: What Does Private Equity in Dermatology Mean for Residents and Millennial Dermatologists?
https://practicaldermatology.com/youngmd-connect/resident-resource-center/viewpoint-what-does-private-equity-in-dermatology-mean-for-residents-and-millennial-dermatologists/23107/One resident’s take on the pros and cons of PE-backed employment and other opportunities for new dermatologists.